FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/8/2026
Repligen (NASDAQ: RGEN) reported Q2 EPS of $0.79, $0.27 better than the analyst estimate of $0.52. Revenue for the quarter came in at $163 million versus the consensus estimate of $144.1 million.
GUIDANCE:
Repligen sees FY2021 revenue of $625-645 million, versus the consensus of $585.9... More

